Seeking Alpha

bakemann

bakemann
Send Message
View as an RSS Feed
View bakemann's Comments BY TICKER:
Latest comments  |  Highest rated
  • Amarin: Mr. NCE Guy Has Left The Building [View article]
    Wow you have to be a little scared, since no NCE only yielded -.73%
    scripts are up yet again
    we will be partnering up before Dec. for Anchor label
    combo data coming anyday
    confirmed buyout interest in AMRN
    consolidation in fish oil industry
    Vascapa has 1-2b annual sales potential
    Good luck being short down here
    AMRN I believe will grossly outerperform the S & P moving forward
    Jun 16, 2013. 07:20 PM | 6 Likes Like |Link to Comment
  • Amarin's Q3 Call Points To Dark Days Ahead [View article]
    QTR
    I think your confusing AMRN with CLSN
    Nov 7, 2013. 10:59 PM | 5 Likes Like |Link to Comment
  • Amarin Reports Solid Vascepa TRx Growth, Stock Holds Its Ground [View article]
    brian , this thing could get nce in a couple of days, or better yet anyday we could wake up, turn the computer on to find AMRN has partnered up. I believe it's not a matter of if but when. better a little early than late
    May 13, 2013. 08:39 PM | 5 Likes Like |Link to Comment
  • All Amarin Eyes On Sunday's Prescription Data [View article]
    I still do not understand Adam's arguement for Vascapa not being approved ?

    "Right now, Amarin has zero data proving these patients benefit from taking a prescription-grade fish oil like Vascepa. The company's FDA submission is based on a phase III study dubbed "Anchor" showing reductions in measurements of triglycerides and "bad" cholesterol. That's not enough. FDA has no incentive and is under no pressure to approve Amarin's application without data demonstrating real clinical benefit."

    when is a reduction in both triglycerides and (bad) cholesterol not considered a real clinical benifit.
    May 24, 2013. 07:23 PM | 3 Likes Like |Link to Comment
  • Amarin Set To Go After Expanded TG Market In Q4 2013! [View instapost]
    steve, thx for all of your dd and articles, pleeeeese don't let A.F. get away with spreading manure around it stinks, looking forward to your next article, I firmly believe we hit a new pre approval high this year although i am deeply concerned over the up coming earnings report
    Apr 23, 2013. 08:25 PM | 2 Likes Like |Link to Comment
  • Orexigen's Weight Loss Drug Will Be Approved Soon And Will Lead Market - Here Is Why [View article]
    what gets me is all the ARNA pumpers say Q failed, yet it sells as good as B with a fraction of sales force , no tv time, and rems
    May 28, 2014. 06:47 PM | 1 Like Like |Link to Comment
  • Future Sales Of Arena Pharmaceuticals' Belviq: Let's Make Some Informed, Quantitative Predictions Using Expected Value [View article]
    so the majic pill does 7k weekly and all of a sudden everyone sees blockbuster
    shoot me a text when it hits 30,000 weekly and maybe I'll turn into an Arniac
    Mar 3, 2014. 08:12 PM | 1 Like Like |Link to Comment
  • Arena Investors Look To Eisai Quarterly Report [View article]
    spence,
    you have talked alot about 30% under reporting in scripts.
    when do actual #'s come out , during quarterly? and if so is that 30% under reporting looking acurate
    THX
    Feb 3, 2014. 09:47 PM | 1 Like Like |Link to Comment
  • Deeper Research: Belviq + Phentermine Equals What? [View instapost]
    really , how soon could this be on the market 2017 ? or is that to early
    and what would there partner have to say about that since they have no contract for sharing rev. for this bel-pfen combo. and since VVUS has REMS and outcomes studies for there phen combo, what does this mean for bel-phen? you see the problems adding up. Really it sounds good and it may work, but isn't this just a pipe dream ?
    Aug 30, 2013. 07:14 PM | 1 Like Like |Link to Comment
  • Amarin: Update On NCE Status And Patent Protection [View article]
    2 things are guaranteed to happen very soon
    1 we will get a nce decision
    2 we will get a 889 patent decision
    place your trade , stock should move substantially up or down
    I for one believe the data pionts toward the mid to upper teens
    Aug 20, 2012. 09:46 PM | 1 Like Like |Link to Comment
  • Orexigen's Weight Loss Drug Will Be Approved Soon And Will Lead Market - Here Is Why [View article]
    AMRN did not meet requirements?
    which requirement did they not meet?
    May 28, 2014. 06:42 PM | Likes Like |Link to Comment
  • While Amarin Continues To Go Rancid, Neptune Will Soar [View article]
    L. A.
    Plus the assumption I am currently running is that CaPre will enter the same market that Vascepa is currently approved in,
    when could this happen?
    THX
    Jan 15, 2014. 08:24 PM | Likes Like |Link to Comment
  • Adcom 2-9 Against Label Expansion [View instapost]
    STEVE R.
    thx, for all the articles and DD you have shared with us over the last couple of years. I lost over 30% of my 401k on this and feel your pain. I take full responsibility for my own actions and will recover ! Good luck to you Sir and I hope to read more of your articles soon
    Baker9517
    Oct 17, 2013. 05:28 PM | Likes Like |Link to Comment
  • AF Backtracking, AMRN Will Be Approved On Time [View instapost]
    adam,
    with all due respect, if there is no clinical meaningfullness to lowering try's, why did the fda approve lavaza and vascapa?
    Sep 25, 2013. 11:10 PM | Likes Like |Link to Comment
  • Amarin Update After CC [View instapost]
    not impressed at all with the Q2 #'s, yet I still believe we see double digits by Dec.
    Aug 9, 2013. 05:08 PM | Likes Like |Link to Comment
COMMENTS STATS
33 Comments
23 Likes